Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Polynucleotide construct capable of displaying fab in a cell-free translation system, and method for manufacturing and screening fab using same

a technology of cell-free translation and polynucleotide constructs, which is applied in the direction of immunoglobulins, instruments, peptides, etc., can solve the problems of difficult efficient screening of fabs composed of two peptide chains and large molecular weight, and achieves easy construction, simple operation, and short screening period

Inactive Publication Date: 2018-01-18
MITSUBISHI TANABE PHARMA CORP +1
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention provides a method for efficiently screening high-affinity Fab fragments using a cell-free display system. This method allows for the construction of large libraries of Fabs with high affinity for target substances. Compared to other methods, the Ymacs method of the present invention allows for the production of a larger number of Fabs with higher affinity for antigens. This method is simple and fast, and can be carried out in a short period.

Problems solved by technology

Although screening of antibodies using the display technology has already been carried out as described above, it has been considered that efficient screening of Fab having a large molecular weight and composed of two peptide chains is difficult with a cell-free display system such as ribosome display.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Polynucleotide construct capable of displaying fab in a cell-free translation system, and method for manufacturing and screening fab using same
  • Polynucleotide construct capable of displaying fab in a cell-free translation system, and method for manufacturing and screening fab using same
  • Polynucleotide construct capable of displaying fab in a cell-free translation system, and method for manufacturing and screening fab using same

Examples

Experimental program
Comparison scheme
Effect test

example 1

[Example 1] Preparation of Model Fab

[0270]As the framework of the Fab to be used in the cell-free Fab display system, the combination of VL k subgroup I and VH subgroup III, which is one of the major antibody subclasses in human, excellent in expression efficiency in E. coli (Kanappik et al., J Mol Biol. (2000) vol. 296, p. 57-86) and reported to be effective in a cell-free scFv display system (Shibui et al., Appl Microbiol Biotechnol. (2009) vol. 84, p. 725-732), was selected. As a model Fab having the above-described framework to be used for confirmation of the performance of the cell-free Fab display system, the human EGFR-2 (Her-2)-reactive Fab reported by Carter et al. (Carter et al., Proc Natl Acad Sci USA. (1992) vol. 89, p. 4285-4289) was selected to provide Fab-HH.

[0271]As another model Fab, Fab-TT was provided by substituting the CDR 1-3 regions in the L chain and the H chain of Fab-HH by the sequence of the INFαR-reactive scFv discovered by the cell-free scFv display syst...

example 2

[Example 2] Evaluation of Activities, Specificities and L Chain-H Chain Interdependencies of Model Fabs

[0275]Each of Her-2 and INFαR (R&D systems) as an antigen protein for the model Fab was diluted with PBS to 1 μg / ml. The diluted antigen was placed on an ELISA plate, and immobilized on the plate by incubation at 4° C. overnight. After washing the well, the model Fab was added thereto to bind the model Fab to the antigen. After washing the well, a 1000-fold diluted HRP-labeled anti-FLAG antibody (Sigma) as a detection antibody was added to the well, to bind the detection antibody to the FLAG tag attached to the model Fab. After washing the well, a colorimetric substrate for HRP was added thereto. When an appropriate degree of coloring was achieved, a stop solution was added to the well, and the absorbance was measured at OD 405 nm. FIG. 11 shows the result of titration of the 4 types of model Fabs over a wide range of concentration using Her-2 as the antigen protein. It can be seen...

example 3

[Example 3] Construction of Vector for Bicistronic Fab-PRD

[0276]A sequence having a very similar amino acid sequence to that of the above-described Fab-HH and reported by Fellouse et al. (Fellouse et al., J. Mol. Biol. (2007) vol. 373, p. 924-940) to show even higher expression efficiency in E. coli was provided as Fab-SS. For the display of this sequence in a cell-free system, a DNA fragment for bicistronic Fab-PRD was artificially synthesized using codons optimized for E. coli. The synthesized fragment was incorporated into a general-purpose phagemid vector pBluescript SK(+) to construct pGAv2-SS. Subsequently, the CDR 1-3 regions in the L chain and the CDR 1-3 regions in the H chain of pGAv2-SS were replaced by the corresponding regions in pTrc Fab-HH, to construct pGAv2-HH. Similarly, using pGAv2-SS and pTrc Fab-TT, pGAv2-TT was constructed. Subsequently, by introducing a XhoI recognition site into the most downstream part of the GS linker downstream of the L chain of pGAv2-HH w...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The polynucleotide construct of (1) or (2) below is used to perform ribosome display, CIS display and / or mRNA display in order to screen a Fab against an antigen of interest: (1) a polynucleotide construct which monocistronically comprises a ribosome-binding sequence, Fab first chain-coding sequence, linker peptide-coding sequence, Fab second chain-coding sequence and scaffold-coding sequence in this order, and further comprises at its 3′-end a structure necessary for maintaining a complex with the Fab encoded by itself; and (2) a polynucleotide construct which comprises a Fab first chain-expressing cistron and a Fab second chain-expressing cistron each containing a ribosome-binding sequence, a Fab first chain-coding sequence or Fab second chain-coding sequence, and a scaffold-coding sequence in this order, the first Fab-expressing cistron further comprising at its 3′-end a ribosome stall sequence, said Fab second chain-expressing cistron further comprising at its 3′-end a structure necessary for maintaining a complex with the Fab encoded by itself.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This patent application is a divisional of co-pending U.S. patent application Ser. No. 13 / 990,654, filed on Jul. 11, 2013, which is the U.S. national phase of International Patent Application No. PCT / JP2011 / 077725, filed Nov. 30, 2011, which claims the benefit of Japanese Patent Application No. 2010-268763, filed on Dec. 1, 2010, which are incorporated by reference in their entireties herein.INCORPORATION-BY-REFERENCE OF MATERIAL ELECTRONICALLY SUBMITTED[0002]Incorporated by reference in its entirety herein is a computer-readable nucleotide / amino acid sequence listing submitted concurrently herewith and identified as follows: 177,375 bytes ASCII (Text) file named “730386SequenceListing.txt,” created Aug. 18, 2017.TECHNICAL FIELD[0003]The present invention relates to a polynucleotide construct that can display Fab in a cell-free translation system, a kit comprising the same, and a production method and a screening method for Fab using the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): G01N33/68C07K16/46C12N15/10
CPCC12N15/1062C12N15/1075C12N15/1041G01N33/6857C07K2317/55C07K2317/31C07K16/468G01N33/6854
Inventor FUJINO, YASUHIROFUJITA, RISAKOWADA, KOUICHIODA, KOTOMIUEDA, TAKUYASHIMIZU, YOSHIHIROKANAMORI, TAKASHI
Owner MITSUBISHI TANABE PHARMA CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com